Trial Profile
A retrospective study to evaluate the impact of serous retinal detachment on the outcomes of ranibizumab-treatment in patients with diabetic macular oedema
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jul 2017
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 11 Jul 2017 New trial record